SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-159588
Filing Date
2016-11-29
Accepted
2016-11-29 16:07:36
Documents
75
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-21140_110q.htm 10-Q 1109943
2 EX-3.1 a16-21140_1ex3d1.htm EX-3.1 54852
3 EX-3.2 a16-21140_1ex3d2.htm EX-3.2 148411
4 EX-31.1 a16-21140_1ex31d1.htm EX-31.1 9093
5 EX-31.2 a16-21140_1ex31d2.htm EX-31.2 9099
6 EX-32.1 a16-21140_1ex32d1.htm EX-32.1 7440
13 GRAPHIC g211401kgi001.jpg GRAPHIC 4854
14 GRAPHIC g211401kgi002.jpg GRAPHIC 3069
  Complete submission text file 0001104659-16-159588.txt   5937603

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rarx-20160930.xml EX-101.INS 1197096
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rarx-20160930.xsd EX-101.SCH 53377
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rarx-20160930_cal.xml EX-101.CAL 45730
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rarx-20160930_def.xml EX-101.DEF 244272
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rarx-20160930_lab.xml EX-101.LAB 441329
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rarx-20160930_pre.xml EX-101.PRE 382863
Mailing Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37926 | Film No.: 162022821
SIC: 2834 Pharmaceutical Preparations